Concepedia

Jordi Bonaventura

JB

30

Publications

2.9K

Citations

22

H-Index

2009

Active since

Affiliations

National Institute on Drug Abuse(Current)

Universitat de Barcelona

Johns Hopkins University

Johns Hopkins Medicine

National Institutes of Health

Jordi Bonaventura is an author at National Institute on Drug Abuse specializing in medicine, pharmacology, and neuropharmacology.

ORCID

Top concepts

Publications per year

2009–2023

30

Publications

30

Chemogenetics revealed: DREADD occupancy and activation via converted clozapine

Juan L. Gomez, Jordi Bonaventura, Wojciech G. Lesniak et al. · Science · 2017 · 1K citations · Full text

, , +18

Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability

Jordi Bonaventura, Sherry Lam, Meghan L. Carlton et al. · Molecular Psychiatry · 2021 · 246 citations · Full text

, , +11

High-potency ligands for DREADD imaging and activation in rodents and monkeys

Jordi Bonaventura, Mark A. G. Eldridge, Feng Hu et al. · Nature Communications · 2019 · 209 citations · Full text

Ultrapotent chemogenetics for research and potential clinical applications

Christopher Magnus, Peter H. Lee, Jordi Bonaventura et al. · Science · 2019 · 192 citations · Full text

Allosteric interactions between agonists and antagonists within the adenosine A <sub>2A</sub> receptor-dopamine D <sub>2</sub> receptor heterotetramer

Jordi Bonaventura, Gemma Navarro, Verònica Casadó-Anguera et al. · Proceedings of the National Academy of Sciences · 2015 · 146 citations · Full text

Rows per page

1–5 of 30